BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 28864377)

  • 1. Antiviral Drug Ribavirin Targets Thyroid Cancer Cells by Inhibiting the eIF4E-β-Catenin Axis.
    Shen X; Zhu Y; Xiao Z; Dai X; Liu D; Li L; Xiao B
    Am J Med Sci; 2017 Aug; 354(2):182-189. PubMed ID: 28864377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic drug rifabutin is effective against lung cancer cells by targeting the eIF4E-β-catenin axis.
    Li J; Huang Y; Gao Y; Wu H; Dong W; Liu L
    Biochem Biophys Res Commun; 2016 Apr; 472(2):299-305. PubMed ID: 26944016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ribavirin augments doxorubicin's efficacy in human hepatocellular carcinoma through inhibiting doxorubicin-induced eIF4E activation.
    Tan J; Ye J; Song M; Zhou M; Hu Y
    J Biochem Mol Toxicol; 2018 Jan; 32(1):. PubMed ID: 29112301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of mTOR/eIF4E by anti-viral drug ribavirin effectively enhances the effects of paclitaxel in oral tongue squamous cell carcinoma.
    Dai D; Chen H; Tang J; Tang Y
    Biochem Biophys Res Commun; 2017 Jan; 482(4):1259-1264. PubMed ID: 27932243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of eIF4E cooperates with chemotherapy and immunotherapy in renal cell carcinoma.
    Cao J; Sun X; Zhang X; Chen D
    Clin Transl Oncol; 2018 Jun; 20(6):761-767. PubMed ID: 29086249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting eIF4E signaling with ribavirin as a sensitizing strategy for ovarian cancer.
    Jin J; Xiang W; Wu S; Wang M; Xiao M; Deng A
    Biochem Biophys Res Commun; 2019 Mar; 510(4):580-586. PubMed ID: 30739792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of eIF4E signaling by ribavirin selectively targets lung cancer and angiogenesis.
    Tan H; He L; Cheng Z
    Biochem Biophys Res Commun; 2020 Aug; 529(3):519-525. PubMed ID: 32736668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of eukaryotic translation initiation factor 4E is effective against chemo-resistance in colon and cervical cancer.
    Xi C; Wang L; Yu J; Ye H; Cao L; Gong Z
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2286-2292. PubMed ID: 29959920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of eukaryotic initiation factor 4E phosphorylation by cercosporamide selectively suppresses angiogenesis, growth and survival of human hepatocellular carcinoma.
    Liu Y; Sun L; Su X; Guo S
    Biomed Pharmacother; 2016 Dec; 84():237-243. PubMed ID: 27662474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting eIF4E inhibits growth, survival and angiogenesis in retinoblastoma and enhances efficacy of chemotherapy.
    Wang G; Li Z; Li Z; Huang Y; Mao X; Xu C; Cui S
    Biomed Pharmacother; 2017 Dec; 96():750-756. PubMed ID: 29049978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibiting MNK Selectively Targets Cervical Cancer via Suppressing eIF4E-Mediated β-Catenin Activation.
    Zhang W; Su X; Li S; Wang Y; Wang Q; Zeng H
    Am J Med Sci; 2019 Sep; 358(3):227-234. PubMed ID: 31327462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ribavirin Inhibits the Activity of mTOR/eIF4E, ERK/Mnk1/eIF4E Signaling Pathway and Synergizes with Tyrosine Kinase Inhibitor Imatinib to Impair Bcr-Abl Mediated Proliferation and Apoptosis in Ph+ Leukemia.
    Shi F; Len Y; Gong Y; Shi R; Yang X; Naren D; Yan T
    PLoS One; 2015; 10(8):e0136746. PubMed ID: 26317515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibiting the MNK-eIF4E-β-catenin axis increases the responsiveness of aggressive breast cancer cells to chemotherapy.
    Li Z; Sun Y; Qu M; Wan H; Cai F; Zhang P
    Oncotarget; 2017 Jan; 8(2):2906-2915. PubMed ID: 27926520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Galeterone sensitizes breast cancer to chemotherapy via targeting MNK/eIF4E and β-catenin.
    Xu Y; Liao S; Wang L; Wang Y; Wei W; Su K; Tu Y; Zhu S
    Cancer Chemother Pharmacol; 2021 Jan; 87(1):85-93. PubMed ID: 33159561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting of Wnt/β-Catenin by Anthelmintic Drug Pyrvinium Enhances Sensitivity of Ovarian Cancer Cells to Chemotherapy.
    Zhang C; Zhang Z; Zhang S; Wang W; Hu P
    Med Sci Monit; 2017 Jan; 23():266-275. PubMed ID: 28090074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinically relevant concentration of anti-viral drug ribavirin selectively targets pediatric osteosarcoma and increases chemosensitivity.
    Chen J; Xu X; Chen J
    Biochem Biophys Res Commun; 2018 Nov; 506(3):604-610. PubMed ID: 30454696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of Mnk-eIF4E pathway sensitizes the efficacy to chemotherapy in anaplastic thyroid cancer.
    Hu K; Zhang J; Yu M; Xiong C
    Future Oncol; 2017 Mar; 13(6):489-498. PubMed ID: 27785922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ribavirin sensitizes nasopharyngeal carcinoma to 5-fluorouracil through suppressing 5-fluorouracil-induced ERK-dependent-eIF4E activation.
    Hu Z; Zhen L; Li Q; Han Q; Hua Q
    Biochem Biophys Res Commun; 2019 Jun; 513(4):862-868. PubMed ID: 31000196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pyrvinium Sensitizes Clear Cell Renal Cell Carcinoma Response to Chemotherapy Via Casein Kinase 1α-Dependent Inhibition of Wnt/β-Catenin.
    Cui L; Zhao J; Liu J
    Am J Med Sci; 2018 Mar; 355(3):274-280. PubMed ID: 29549930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic effects of antibiotic drug tigecycline against cervical squamous cell carcinoma by inhibiting Wnt/β-catenin signaling.
    Li H; Jiao S; Li X; Banu H; Hamal S; Wang X
    Biochem Biophys Res Commun; 2015 Nov; 467(1):14-20. PubMed ID: 26427870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.